<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362662/" ref="ordinalpos=2205&amp;ncbi_uid=7288731&amp;link_uid=PMC4362662" image-link="/pmc/articles/PMC4362662/figure/Fig5/" class="imagepopup">Figure 5.  From: Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> mediated Snail/E-cadherin expression. </a></div><br /><div class="p4l_captionBody"> <b>Resveratrol repressed expressions of EMT-induced transcription factors and Smads signaling pathway.</b> Whole or cell extracts of different cellular compartments from LoVo cells were probed for <b>(A)</b> Slug Snail, ZEB1, Twist, and <b>(B)</b> p-Smad2/3, Smad2/3. **P &lt; 0.01, compared with group without treatment of TGF-β1 and resveratrol. <b>(C)</b> LoVo cells treated with TGF-β1 or (and) TGFβRI/II inhibitor (LY2109761) were analyzed for the Snail and E-cadherin mRNA expression by RT-PCR, GAPDH was chosen as a control. <b>(D)</b> Whole or cell extracts of different cellular compartments from LoVo cells were probed for p-Smad2/3, Smad2/3, Snail and E-cadherin expression. **P &lt; 0.01, compared with group without treatment of TGF-β1 and LY2109761.</div></div>